Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 12, Issue 12, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-19
DOI
10.1038/s41408-022-00764-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcome prediction by the knowledge bank approach in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation
- (2022) Lisa Herrmann et al. AMERICAN JOURNAL OF HEMATOLOGY
- Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel
- (2022) Hartmut Döhner et al. BLOOD
- Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning
- (2022) Jan-Niklas Eckardt et al. HAEMATOLOGICA
- Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia
- (2022) Ga-Young Song et al. BONE MARROW TRANSPLANTATION
- Validation of the 2022 European Leukemianet Genetic Risk Stratification of Acute Myeloid Leukemia
- (2022) Christian Rausch et al. BLOOD
- Clinical value of the measurable residual disease status within the ELN2017 risk groups in AML patients undergoing allogeneic stem cell transplantation
- (2021) Madlen Jentzsch et al. AMERICAN JOURNAL OF HEMATOLOGY
- CEBPA bZip Mutations are Associated with Favorable Prognosis in de novo AML: A Report from the Children's Oncology Group
- (2021) Katherine Tarlock et al. BLOOD
- Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantation
- (2021) Juliane Grimm et al. AMERICAN JOURNAL OF HEMATOLOGY
- CEBPA Mutations in 4708 Patients with Acute Myeloid Leukemia - Differential Impact of bZIP and TAD Mutations on Outcome
- (2021) Franziska Taube et al. BLOOD
- Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement
- (2021) Marius Bill et al. Journal of Hematology & Oncology
- Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification
- (2021) Inge van der Werf et al. Blood Advances
- Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia
- (2021) Satoshi Wakita et al. Blood Advances
- High expression of the stem cell marker GPR56 at diagnosis identifies acute myeloid leukemia patients at higher relapse risk after allogeneic stem cell transplantation in context with the CD34+/CD38- population
- (2020) Madlen Jentzsch et al. HAEMATOLOGICA
- Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
- (2020) Tobias Herold et al. LEUKEMIA
- Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results
- (2020) Claude Gardin et al. Blood Advances
- A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia.
- (2020) Laurène Fenwarth et al. BLOOD
- Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation
- (2020) Juliane Grimm et al. Blood Advances
- ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation
- (2020) Madlen Jentzsch et al. BONE MARROW TRANSPLANTATION
- Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients
- (2018) Marius Bill et al. ANNALS OF HEMATOLOGY
- Validation of the prognostic value of knowledge bank approach to determine AML prognosis in real life
- (2018) Sarah Huet et al. BLOOD
- Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation
- (2018) Juliane Grimm et al. BONE MARROW TRANSPLANTATION
- Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3 -internal tandem duplication genotypes
- (2018) Prajwal C. Boddu et al. CANCER
- Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)
- (2017) Nicolaus Kröger et al. JOURNAL OF CLINICAL ONCOLOGY
- Precision oncology for acute myeloid leukemia using a knowledge bank approach
- (2017) Moritz Gerstung et al. NATURE GENETICS
- High BAALC copy numbers in peripheral blood prior to allogeneic transplantation predict early relapse in acute myeloid leukemia patients
- (2017) Madlen Jentzsch et al. Oncotarget
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation
- (2015) Christian Pfrepper et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
- (2014) R. C. Lindsley et al. BLOOD
- Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients
- (2013) A Bryant et al. BONE MARROW TRANSPLANTATION
- Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia
- (2012) Krzysztof Mrózek et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now